Apollo Endosurgery touts results of stomach-stapling study

 

Apollo Endosurgery’s OverStitch device

Apollo Endosurgery (NSDQ:APEN) has reported key data from 1,000 patients who underwent endoscopic gastroplasty using the company’s OverStitch device.

Published in the journal Gastrointestinal Endoscopy, the data include a mean total weight loss of 14.8%±8.5% at 18 months. Three months following surgery, the impact on obesity-related comorbidities included the complete remission of:

• • 13 of 17 cases of type 2 diabetes.
  • All 28 cases of hypertension.
  • 18 of 32 cases of dyslipidemia.

Get the full story on our sister site, Medical Design & Outsourcing.

The post Apollo Endosurgery touts results of stomach-stapling study appeared first on MassDevice.

from MassDevice https://ift.tt/2ttOodE